Rangaswamy Govindarajan

Summary

Affiliation: University of Arkansas for Medical Sciences
Country: USA

Publications

  1. doi request reprint Bevacizumab and erlotinib in previously untreated inoperable and metastatic hepatocellular carcinoma
    Rangaswamy Govindarajan
    Division of Hematology Oncology and Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Am J Clin Oncol 36:254-7. 2013
  2. ncbi request reprint Irinotecan/thalidomide in metastatic colorectal cancer
    Rangaswamy Govindarajan
    University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Oncology (Williston Park) 16:23-6. 2002
  3. ncbi request reprint Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
    Rangaswamy Govindarajan
    Central Arkansas Veterans Health Care System, and the University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    J Clin Oncol 25:1476-81. 2007
  4. ncbi request reprint Racial differences in the outcome of patients with colorectal carcinoma
    Rangaswamy Govindarajan
    Division of Hematology Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences and Arkansas Cancer Research Center, Little Rock, Arkansas 72205, USA
    Cancer 97:493-8. 2003
  5. ncbi request reprint Heparin-induced skin necrosis associated with thrombocytopenia and acquired protein C and protein S deficiency
    H Keshava Prasad
    Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Am J Hematol 82:1116-7. 2007
  6. ncbi request reprint Clinical trial registration and the ICMJE
    Omar Khalil
    JAMA 293:157; author reply 158. 2005
  7. ncbi request reprint Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006
    Rangaswamy Govindarajan
    J Clin Oncol 24:e48. 2006

Collaborators

Detail Information

Publications7

  1. doi request reprint Bevacizumab and erlotinib in previously untreated inoperable and metastatic hepatocellular carcinoma
    Rangaswamy Govindarajan
    Division of Hematology Oncology and Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Am J Clin Oncol 36:254-7. 2013
    ..To evaluate the combination of erlotinib and bevacizumab in subjects with hepatocellular carcinoma (HCC) who are not candidates for local therapy...
  2. ncbi request reprint Irinotecan/thalidomide in metastatic colorectal cancer
    Rangaswamy Govindarajan
    University of Arkansas for Medical Sciences, Little Rock 72205, USA
    Oncology (Williston Park) 16:23-6. 2002
    ..Patients with metastatic colorectal cancer are receiving 350 mg/m2 of irinotecan every 3 weeks plus 400 mg/m2/d of thalidomide. Preliminary response and safety data are presented for 18 enrolled patients...
  3. ncbi request reprint Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
    Rangaswamy Govindarajan
    Central Arkansas Veterans Health Care System, and the University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    J Clin Oncol 25:1476-81. 2007
    ..To assess the influence of thiazolidinediones (TZDs), which are PPAR ligands used to treat diabetes mellitus, a retrospective analysis of a database from 10 Veteran Affairs medical centers was conducted...
  4. ncbi request reprint Racial differences in the outcome of patients with colorectal carcinoma
    Rangaswamy Govindarajan
    Division of Hematology Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences and Arkansas Cancer Research Center, Little Rock, Arkansas 72205, USA
    Cancer 97:493-8. 2003
    ..The impact of treatments received and the role of socioeconomic factors such as income, education, and poverty levels were studied...
  5. ncbi request reprint Heparin-induced skin necrosis associated with thrombocytopenia and acquired protein C and protein S deficiency
    H Keshava Prasad
    Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
    Am J Hematol 82:1116-7. 2007
    ..We could not find any previous case reports of heparin-induced skin necrosis associated with isolated protein C deficiency, or combined protein C and protein S deficiency...
  6. ncbi request reprint Clinical trial registration and the ICMJE
    Omar Khalil
    JAMA 293:157; author reply 158. 2005
  7. ncbi request reprint Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006
    Rangaswamy Govindarajan
    J Clin Oncol 24:e48. 2006